1. Home
  2. COLL vs KRO Comparison

COLL vs KRO Comparison

Compare COLL & KRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • KRO
  • Stock Information
  • Founded
  • COLL 2002
  • KRO 1916
  • Country
  • COLL United States
  • KRO United States
  • Employees
  • COLL N/A
  • KRO N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • KRO Major Chemicals
  • Sector
  • COLL Health Care
  • KRO Industrials
  • Exchange
  • COLL Nasdaq
  • KRO Nasdaq
  • Market Cap
  • COLL 1.1B
  • KRO 1.1B
  • IPO Year
  • COLL 2015
  • KRO N/A
  • Fundamental
  • Price
  • COLL $33.35
  • KRO $9.54
  • Analyst Decision
  • COLL Strong Buy
  • KRO Hold
  • Analyst Count
  • COLL 5
  • KRO 3
  • Target Price
  • COLL $43.80
  • KRO $12.00
  • AVG Volume (30 Days)
  • COLL 486.5K
  • KRO 184.5K
  • Earning Date
  • COLL 02-20-2025
  • KRO 03-05-2025
  • Dividend Yield
  • COLL N/A
  • KRO 2.10%
  • EPS Growth
  • COLL 757.11
  • KRO N/A
  • EPS
  • COLL 2.16
  • KRO 0.82
  • Revenue
  • COLL $599,245,000.00
  • KRO $1,864,100,000.00
  • Revenue This Year
  • COLL $13.20
  • KRO $25.77
  • Revenue Next Year
  • COLL $17.63
  • KRO $6.54
  • P/E Ratio
  • COLL $15.42
  • KRO $11.65
  • Revenue Growth
  • COLL 9.62
  • KRO 15.87
  • 52 Week Low
  • COLL $28.39
  • KRO $8.26
  • 52 Week High
  • COLL $42.29
  • KRO $14.50
  • Technical
  • Relative Strength Index (RSI)
  • COLL 62.31
  • KRO 43.53
  • Support Level
  • COLL $32.29
  • KRO $8.78
  • Resistance Level
  • COLL $33.99
  • KRO $9.56
  • Average True Range (ATR)
  • COLL 1.29
  • KRO 0.27
  • MACD
  • COLL 0.51
  • KRO 0.07
  • Stochastic Oscillator
  • COLL 87.40
  • KRO 67.26

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About KRO Kronos Worldwide Inc

Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in a variety of products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second-largest product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.

Share on Social Networks: